The RPL3 antibody is a research tool designed to detect ribosomal protein L3 (RPL3), a critical component of the 60S ribosomal subunit involved in protein synthesis. RPL3. encoded by the *RPL3* gene in humans, plays a structural role in ribosome assembly and participates in translation by facilitating tRNA binding and peptidyl transferase activity. Beyond its canonical function, RPL3 has been implicated in stress responses, apoptosis regulation, and cellular proliferation, with dysregulation linked to cancer, neurodegenerative disorders, and ribosomopathies. The antibody is widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to study RPL3 expression, localization, and interactions in various tissues and disease models. Its specificity makes it valuable for investigating ribosome biogenesis defects, chemoresistance mechanisms in cancer, or cellular adaptations to metabolic stress. Recent studies also explore RPL3's role in viral infections, where ribosomal proteins may interact with viral components. Validation parameters, including target knockout controls and cross-reactivity checks, ensure reliability. Researchers utilize RPL3 antibodies to uncover molecular pathways connecting ribosomal dysfunction to disease, highlighting its importance in both basic and translational bioscience.